(CZR) Caesars Entertainment - Ratings and Ratios
Casino, Sportsbook, Hotel, Dining, Entertainment
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 43.4% |
| Value at Risk 5%th | 67.5% |
| Relative Tail Risk | -5.34% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.50 |
| Alpha | -51.18 |
| CAGR/Max DD | -0.27 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.488 |
| Beta | 1.503 |
| Beta Downside | 1.313 |
| Drawdowns 3y | |
|---|---|
| Max DD | 68.61% |
| Mean DD | 34.21% |
| Median DD | 34.36% |
Description: CZR Caesars Entertainment November 05, 2025
Caesars Entertainment, Inc. (NASDAQ:CZR) is a U.S.-based gaming and hospitality operator that owns, leases, brands, or manages casino-resort properties across 18 states. Its venues feature slot machines, video lottery terminals, e-tables, table games (including poker), and extensive hotel accommodations. The company also runs retail and online sports wagering in 32 North American jurisdictions and iGaming in five, complemented by dining, nightlife, entertainment venues, and staffing services.
Key recent metrics indicate that Caesars generated approximately $7.2 billion in total revenue for FY 2023, with adjusted EBITDA of $1.1 billion and a net gaming revenue (NGR) growth of 7% year-over-year, driven largely by a 15% increase in its online sports betting platform. The firm carries roughly $13 billion of total debt, giving it an interest-coverage ratio near 3.5×, while discretionary consumer spending and tourism recovery remain primary macro-economic levers for its performance. Additionally, the broader casino sector is being reshaped by the rapid adoption of digital betting channels, which is expected to lift overall wagering volumes by 4–5% annually.
If you want a data-rich, side-by-side comparison of Caesars’ valuation and risk profile, ValueRay’s analytics dashboard can provide the deeper dive you need.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (-241.0m TTM) > 0 and > 6% of Revenue (6% = 682.1m TTM) |
| FCFTA 0.01 (>2.0%) and ΔFCFTA 1.48pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -4.34% (prev -3.26%; Δ -1.08pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.04 (>3.0%) and CFO 1.33b > Net Income -241.0m (YES >=105%, WARN >=100%) |
| Net Debt (24.02b) to EBITDA (3.60b) ratio: 6.68 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.78 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (207.0m) change vs 12m ago -3.72% (target <= -2.0% for YES) |
| Gross Margin 47.15% (prev 52.05%; Δ -4.89pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 35.05% (prev 34.19%; Δ 0.87pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.93 (EBITDA TTM 3.60b / Interest Expense TTM 2.34b) >= 6 (WARN >= 3) |
Altman Z'' -0.07
| (A) -0.02 = (Total Current Assets 1.73b - Total Current Liabilities 2.23b) / Total Assets 31.90b |
| (B) -0.10 = Retained Earnings (Balance) -3.05b / Total Assets 31.90b |
| (C) 0.07 = EBIT TTM 2.18b / Avg Total Assets 32.43b |
| (D) -0.11 = Book Value of Equity -2.96b / Total Liabilities 27.93b |
| Total Rating: -0.07 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 56.10
| 1. Piotroski 3.50pt |
| 2. FCF Yield 1.39% |
| 3. FCF Margin 3.54% |
| 4. Debt/Equity 6.57 |
| 5. Debt/Ebitda 6.68 |
| 6. ROIC - WACC (= 5.19)% |
| 7. RoE -6.07% |
| 8. Rev. Trend 47.79% |
| 9. EPS Trend 39.18% |
What is the price of CZR shares?
Over the past week, the price has changed by -4.53%, over one month by +1.04%, over three months by -13.45% and over the past year by -30.01%.
Is CZR a buy, sell or hold?
- Strong Buy: 10
- Buy: 2
- Hold: 3
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CZR price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 32 | 36.8% |
| Analysts Target Price | 32 | 36.8% |
| ValueRay Target Price | 19.2 | -17.9% |
CZR Fundamental Data Overview January 01, 2026
P/E Forward = 35.5872
P/S = 0.4303
P/B = 1.2693
P/EG = 3.2616
Beta = 2.048
Revenue TTM = 11.37b USD
EBIT TTM = 2.18b USD
EBITDA TTM = 3.60b USD
Long Term Debt = 11.68b USD (from longTermDebt, last quarter)
Short Term Debt = 114.0m USD (from shortTermDebt, last quarter)
Debt = 24.86b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 24.02b USD (from netDebt column, last quarter)
Enterprise Value = 28.92b USD (4.89b + Debt 24.86b - CCE 836.0m)
Interest Coverage Ratio = 0.93 (Ebit TTM 2.18b / Interest Expense TTM 2.34b)
FCF Yield = 1.39% (FCF TTM 403.0m / Enterprise Value 28.92b)
FCF Margin = 3.54% (FCF TTM 403.0m / Revenue TTM 11.37b)
Net Margin = -2.12% (Net Income TTM -241.0m / Revenue TTM 11.37b)
Gross Margin = 47.15% ((Revenue TTM 11.37b - Cost of Revenue TTM 6.01b) / Revenue TTM)
Gross Margin QoQ = 36.98% (prev 51.08%)
Tobins Q-Ratio = 0.91 (Enterprise Value 28.92b / Total Assets 31.90b)
Interest Expense / Debt = 2.34% (Interest Expense 581.0m / Debt 24.86b)
Taxrate = 39.06% (-25.0m / -64.0m)
NOPAT = 1.33b (EBIT 2.18b * (1 - 39.06%))
Current Ratio = 0.78 (Total Current Assets 1.73b / Total Current Liabilities 2.23b)
Debt / Equity = 6.57 (Debt 24.86b / totalStockholderEquity, last quarter 3.78b)
Debt / EBITDA = 6.68 (Net Debt 24.02b / EBITDA 3.60b)
Debt / FCF = 59.61 (Net Debt 24.02b / FCF TTM 403.0m)
Total Stockholder Equity = 3.97b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.76% (Net Income -241.0m / Total Assets 31.90b)
RoE = -6.07% (Net Income TTM -241.0m / Total Stockholder Equity 3.97b)
RoCE = 13.91% (EBIT 2.18b / Capital Employed (Equity 3.97b + L.T.Debt 11.68b))
RoIC = 8.28% (NOPAT 1.33b / Invested Capital 16.03b)
WACC = 3.09% (E(4.89b)/V(29.75b) * Re(11.55%) + D(24.86b)/V(29.75b) * Rd(2.34%) * (1-Tc(0.39)))
Discount Rate = 11.55% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.11%
[DCF Debug] Terminal Value 56.46% ; FCFE base≈403.0m ; Y1≈264.6m ; Y5≈121.0m
Fair Price DCF = 7.32 (DCF Value 1.49b / Shares Outstanding 204.1m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 39.18 | EPS CAGR: 236.4% | SUE: 0.16 | # QB: 0
Revenue Correlation: 47.79 | Revenue CAGR: 2.76% | SUE: -0.48 | # QB: 0
EPS next Quarter (2026-03-31): EPS=-0.09 | Chg30d=-0.025 | Revisions Net=+0 | Analysts=3
EPS next Year (2026-12-31): EPS=0.47 | Chg30d=-0.134 | Revisions Net=-1 | Growth EPS=+145.9% | Growth Revenue=+2.6%
Additional Sources for CZR Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle